Viewing Study NCT02823951


Ignite Creation Date: 2025-12-24 @ 11:53 PM
Ignite Modification Date: 2026-02-27 @ 5:09 PM
Study NCT ID: NCT02823951
Status: COMPLETED
Last Update Posted: 2018-03-01
First Post: 2016-03-03
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Patient Real-world Clinical, Neurological, Tolerability, and Safety Outcomes for Tecfidera® and Rebif®
Sponsor: IMS HEALTH GmbH & Co. OHG
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: MS200136_0037
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View